Moody Aldrich Partners’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,265
| Closed | -$874K | – | 177 |
|
|
2021
Q1 | $874K | Buy |
1,265
+20
| +2% | +$13.8K | 0.13% | 130 |
|
|
2020
Q4 | $920K | Buy |
1,245
+3
| +0.2% | +$2.22K | 0.15% | 120 |
|
|
2020
Q3 | $862K | Buy |
1,242
+31
| +3% | +$21.5K | 0.18% | 109 |
|
|
2020
Q2 | $1.03M | Sell |
1,211
-3,767
| -76% | -$3.19M | 0.22% | 104 |
|
|
2020
Q1 | $1.78M | Buy |
+4,978
| New | +$1.78M | 0.54% | 71 |
|